2. Case:
A 32 year lady from Pachkhal presented with:
Itching of b/l eyes for 2 weeks along with
redness and ropy discharge from both the
eyes. There was no any associated pain.
She complains of seasonal recurrance of the
above symptoms.
3. On Examination
• VA 6/9 No improvement on pinhole
6/9
There is presence of circumcorneal hyperaemia.
The cornea is clear.
No restriction of EOM movement.
The Pupils are Round, Regular and Reactive.
Both pupil have brisk response on Dir./Indirect light reflex.
RAPD absent. No any gross Squint.
On Slit lamp Examination:
Small papilla present on the palpebral conjunctiva in B/L eye.
Hyperaemia and chemosis in the conjunctiva.
AC clear.
4. Management
• She was diagnosed as Acute Allergic conjunctivitis
and managed on the following medications.
1. Gtt. Winolap [ Olopatidine 0.1%(w/v) – Dual action
antihistamines and mast cell stabilizers] BD 1 drop
B/E for 2 weeks.
2. Gtt. RefeshTear [Carboxymethyl cellulose
0.5%(w/v)] QID 1drop B/E for 1 month
3. Advice:
Avoid direct sunlight, dust and any other allergens.
Maintain ocular hygiene.
F/U after 2 weeks / SOS
5. Allergic conjunctivitis
Inflammation of conjunctiva due to allergic or
hypersensitive reaction which may be
immediate (humoral ) or delayed (cellular) to
specific antigens.
8. Simple Allergic Conjunctivitis
Mild ,non specific IgE mediated Type I
hypersensitivity reaction
Etiology :
Hay fever conjunctivitis : associated with
allergic rhinitis
Allergens : pollens , grass , animal dandruffs
SAC: common , d/t: grass pollens
PAC: not common , d/t: house dust and mites
11. Treatment
Elimination of allergens if possible
Cold compresses
Antihistamines oral/ topical (epinistine ,
fexofenadrine)
Mast cell stabilizers (sodium cromoglycate ,
lodaximide)
Combination( olopatidine,patalon,azelastine)
Topical corticosteroids
Immunosuppressant's (cyclosporin) for steroid
resistant cases
12. Vernal keratoconjunctivitis or spring catarrh
Recurrent, Bilateral , self limiting allergic inflammation
of the conjunctiva having a periodic seasonal
incidence.
More common in males
Type 1 IgE mediated.
More common in warm, dry climates especially in
summer.
13. Clinical features :
– 98% bilateral, can be asymmetric.
– Intense ocular itching, Lacrimation, Photophobia,
blepharospasm, blurred vision, FB sensation , burning
and difficulty opening eyes in the morning.
– Thick mucous ropy discharge , Pseudoptosis due to large
papillae.
– Giant papillae on the superior Palpebral conjunctiva are
the clinical hallmark.
14. Diffuse papillary hypertrophy, on
superior tarsus
Papillae have a flattopped polygonal
appearance resembling COBBLESTONES
Palpebral form
Severe cases- Giant papillae, which
may be coated with mucus
15. Limbal / Bulbar form
May start as a thickening & opacification of
limbus
Limbal nodules – Mucoid nodules, which are
gelatinous, elevated. Horner-Trantas dots – composed mainly of
eosinophils and epithelial debris (limbal
apices)
18. ATOPIC KERATOCONJUNCTIVITIS
• Atopic keratoconjunctivitis (AKC) is a rare bilateral disease that
typically develops in adulthood (peak incidence 30–50 years) following
a long history of atopic dermatitis (eczema); asthma is also extremely
common in these patients.
• Whereas VKC is more frequently seasonal and generally worse in
the spring, AKC tends to be perennial and is often worse in the
winter.
Serem IgE raised.
19. A) Severe eyelid involvement.
lid margins: inflamed with round
posterior borders
(B) infiltration and scarring of the
tarsal conjunctiva. watery discharge,
milky appearance , very fine papilla
(C) Forniceal shortening.
hyperaemia scarring with shrinkage
20. Symptoms :
itching , soreness , dry sensation , mucoid
discharge, Hardening Eyelid, phtophobia or
blurred vision
Signs :
Eye lids
lid margins: inflamed with round posterior borders
Extra lid fold – Dennie Morgan fold
Loss of lateral eyebrow – Hortoghe’s sign
conjunctiva :
Tarsal : watery discharge, milky appearance , very
fine papilla , hyperaemia scarring with shrinkage
Limbal: Limbal spots and Trantas dots (as in VKC)
21. Treatment
On same line as VKC except that it is generally
less responsive and requires more intensive
and prolonged therapy.
Lid margin inflammation and facial eczema
should be treated with oral NSAIDs, oral
antibiotics (Doxycycline or azithromycin) and
local application of steroid and antibiotic eye
ointment.
22. Giant (mechanically induced) papillary conjunctivitis
Mechanically induced papillary conjunctivitis occur secondary to
mechanical stimuli of the tarsal conjunctiva.
It is most frequently encountered with contact lens (CL) wear ie
papillary conjunctivitis (CLPC).
Proteinaceous deposits and cellular debris on the contact lens
surface may occur.
Symptoms consist of a foreign body sensation, redness, itching,
increased mucus production, blurring and loss of CL tolerance
Signs
Variable mucous discharge. Substantial CL protein deposits
Excessive CL mobility due to upper lid capture.
Superior tarsal hyperaemia and papillae.
23. Contact allergic blepharoconjunctivitis.
Mucous discharge.
Ocular prosthesis causing giant papillary
Conjunctivitis.
Superior tarsal hyperaemia and papillae
‘giant’ papillae are >1.0 mm in diameter
24. Treatment
1. Removal of the stimulus
2. Ensure effective cleaning of CL or prosthesis
3. Topical
• Mast cell stabilizers.
• Antihistamines, non-steroidal anti-inflammatory
agents and combined antihistamines/mast cell
stabilizers may each be of benefit.
• Topical steroids can be used for the acute phase
of resistant cases.
25. Phlyctenular keratoconjunctivitis (PKC)
Nodular affection occurring as an allergic
response by conjunctiva and corneal
epithelium to some endogenous allergens
Delayed hypersensitivity ( type IV) response to
endogenous microbial proteins : Tuberculous
protein, Staphylococcal protein , parasitic
protein .
26. 1. Stage of nodule formation : exudation and
infiltration of lymphocytes into deeper layers.
2. Stage of ulceration : Necrosis of apex of
nodule leading to ulcer formation ,
3. Stage of granulation
4. Stage of healing
28. Treatment
• A short course of topical steroid accelerates
healing and is often given with a topical
antibiotic.
• Atropine 1 % if cornea involved.
• Recurrent troublesome disease may require
an oral tetracycline.
• It is important to treat associated blepharitis.
29. Contact Dermatoconjunctivitis
• It is an allergic disorder, involving conjunctiva and skin of
lids along with surrounding area of face.
• It is in a delayed hypersensitivity (type IV)
response to prolonged contact with chemicals and drugs.
Drugs that produce contact dermoconjunctivitis are
atropine, penicillin, neomycin, soframycin and gentamycin.
Treatment consists of:
1. Discontinuation of the causative medication.
2. Topical steroid eye drops to relieve symptoms.
3. Application of steroid ointment on the involved
skin.